Edition:
United Kingdom

GlaxoSmithKline Pharmaceuticals Ltd (GLAX.NS)

GLAX.NS on National Stock Exchange of India

1,437.90INR
17 Jan 2019
Change (% chg)

Rs-2.60 (-0.18%)
Prev Close
Rs1,440.50
Open
Rs1,440.10
Day's High
Rs1,450.00
Day's Low
Rs1,405.50
Volume
14,037
Avg. Vol
18,560
52-wk High
Rs1,800.05
52-wk Low
Rs1,010.00

Revenue & Earnings Per Share

 
*Note: Units in Millions ofRupee
**Note: Units in Rupee

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Mar-19 7 33,347.60 37,704.90 31,555.00 35,770.90
Year Ending Mar-20 6 36,650.50 39,698.00 34,643.00 39,335.00
Earnings (per share)
Year Ending Mar-19 7 26.27 30.60 22.53 26.41
Year Ending Mar-20 6 31.12 39.60 25.21 29.08
Sales and Profit Figures in India Rupee (INR);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 62.45 30.48 33.71
P/E High - Last 5 Yrs. -- 45.02 49.93
P/E Low - Last 5 Yrs. -- 23.66 24.27
Beta 0.17 0.90 0.90
Price to Sales (TTM) 14.01 4.12 6.28
Price to Book (MRQ) -- 5.11 5.27
Price to Tangible Book (MRQ) -- 5.85 6.79
Price to Cash Flow (TTM) 174.34 24.01 24.84
% Owned Institutions -- 0.91 1.69

Dividends

  Company industry sector
Dividend Yield 1.24 1.49 1.40
Dividend Yield - 5 Year Avg -- 1.51 1.42
Dividend 5 Year Growth Rate -- 4.13 4.83
Payout Ratio(TTM) 0.00 43.96 41.08

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 4.30 9.72
Sales (TTM) vs TTM 1 Yr. Ago -- 4.14 5.87
Sales - 5 Yr. Growth Rate -- 10.87 11.20
EPS (MRQ) vs Qtr. 1 Yr. Ago -- 45.04 47.26
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 10.28 10.82
Capital Spending - 5 Yr. Growth Rate -- 15.84 15.18

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.15 2.26
Current Ratio (MRQ) -- 2.98 3.08
LT Debt to Equity (MRQ) -- 8.86 11.38
Total Debt to Equity (MRQ) -- 12.90 16.13
Interest Coverage (TTM) -- 33.85 29.51

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 23.80 53.65 53.78
Gross Margin - 5 Yr. Avg. -- 51.65 52.17
EBITD Margin (TTM) 29.85 -- --
EBITD - 5 Yr. Avg -- 17.95 12.88
Operating Margin (TTM) 33.89 14.28 6.20
Operating Margin - 5 Yr. Avg. -- 14.22 8.32
Pre-Tax Margin (TTM) 33.89 14.84 7.17
Pre-Tax Margin - 5 Yr. Avg. -- 14.67 8.62
Net Profit Margin (TTM) 23.12 11.08 3.30
Net Profit Margin - 5 Yr. Avg. -- 11.02 4.89
Effective Tax Rate (TTM) 31.77 23.02 22.88
Effective Tax Rate - 5 Yr. Avg. -- 23.17 23.39

Efficiency

  Company industry sector
Revenue/Employee (TTM) 3,109,462 959,798,993 844,239,900
Net Income/Employee (TTM) 718,922 113,819,317 100,064,185
Receivable Turnover (TTM) -- 5.72 5.72
Inventory Turnover (TTM) -- 2.61 3.48
Asset Turnover (TTM) -- 0.97 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 11.55 11.08
Return on Assets - 5 Yr. Avg. -- 12.93 12.21
Return on Investment (TTM) -- 14.98 14.48
Return on Investment - 5 Yr. Avg. -- 16.85 15.88
Return on Equity (TTM) -- 16.31 15.99
Return on Equity - 5 Yr. Avg. -- 17.77 17.00
  1 Year 3 Year 5 Year
Sales % 5.71 -- --
EPS (TTM) % -10.46 -- --
Dividend % -40.00 -- --
Note: Units in Millions of US Dollars

Performance for GlaxoSmithKline Pharmaceuticals Ltd

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -2.25 -2.64 99 22
13 Week -6.52 -7.86 99 39
26 Week -11.71 -17.56 99 33
52 Week -17.27 -26.91 99 9
YTD -11.53 -25.96 99 26
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 11.55%
# of Holders: 18
Total Shares Held: 19,566,218
3 Mo. Net Change: -29,609
# New Positions: 0
# Closed Positions: 1
# Increased Positions: 2
# Reduced Positions: 5
# Net Buyers: -3
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.